FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2122424316> ?p ?o ?g. }

• W2122424316 endingPage "353" @default.
• W2122424316 startingPage "345" @default.
• W2122424316 abstract "Anticoagulation in cardioversion and ablation of atrial fibrillation is imperative for reducing thrombo-embolic events. Ample information is available about the use of warfarin and vitamin K antagonists (VKA) but few trials examine safety and efficacy of rivaroxaban in these procedures. We aim to explore the hypothesis that rivaroxaban causes equal thrombo-embolic and bleeding events when used in atrial fibrillation patients undergoing ablation or cardioversion compared to VKA.We searched the online databases as well as conference abstracts till December 2014 for studies comparing rivaroxaban with VKA in atrial fibrillation patients undergoing catheter ablation or cardioversion. We report events as Odds ratio using random effects model except when event rates were less than 1% we used Peto Odds Ratio.A total of 8872 atrial fibrillation patients in 15 studies undergoing either catheter ablation or cardioversion were included in this analysis. There were significantly lower stroke events with rivaroxaban compared with VKA (Peto Odds Ratio (POR) 0.33, 95% confidence interval (CI) [0.11, 0.95]; P=0.04), and significantly less thrombo-embolic events with rivaroxaban compared with VKA (POR 0.46, 95% CI [0.21, 0.97]; P=0.04). Major and minor bleeding were equal with rivaroxaban versus VKA (Odds Ratio (OR) 0.92, 95% CI [0.62, 1.36]; P=0.68) and (OR 0.81,95% CI [0.58, 1.11]; P=0.19) respectively.The use of rivaroxaban in ablation and cardioversion of atrial fibrillation may be associated with decreased risk of stroke and thromboembolism with equal bleeding risk compared to VKA." @default.
• W2122424316 created "2016-06-24" @default.
• W2122424316 creator A5002582638 @default.
• W2122424316 creator A5006163992 @default.
• W2122424316 creator A5012496275 @default.
• W2122424316 creator A5028923340 @default.
• W2122424316 creator A5055127245 @default.
• W2122424316 creator A5084192381 @default.
• W2122424316 creator A5086292433 @default.
• W2122424316 creator A5091070572 @default.
• W2122424316 date "2015-05-01" @default.
• W2122424316 modified "2023-09-27" @default.
• W2122424316 title "Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation" @default.
• W2122424316 cites W1146732871 @default.
• W2122424316 cites W1968492659 @default.
• W2122424316 cites W1968678408 @default.
• W2122424316 cites W1979423827 @default.
• W2122424316 cites W1992956108 @default.
• W2122424316 cites W1996688101 @default.
• W2122424316 cites W2012107441 @default.
• W2122424316 cites W2028162842 @default.
• W2122424316 cites W2029731076 @default.
• W2122424316 cites W2055375232 @default.
• W2122424316 cites W2056242675 @default.
• W2122424316 cites W2065138795 @default.
• W2122424316 cites W2078023795 @default.
• W2122424316 cites W2103355478 @default.
• W2122424316 cites W2104716437 @default.
• W2122424316 cites W2105637659 @default.
• W2122424316 cites W2112450983 @default.
• W2122424316 cites W2119827548 @default.
• W2122424316 cites W2119976281 @default.
• W2122424316 cites W2124430757 @default.
• W2122424316 cites W2128076015 @default.
• W2122424316 cites W2128943756 @default.
• W2122424316 cites W2146673314 @default.
• W2122424316 cites W2156098321 @default.
• W2122424316 cites W2156814079 @default.
• W2122424316 cites W2159357148 @default.
• W2122424316 cites W2166603122 @default.
• W2122424316 cites W2481569543 @default.
• W2122424316 cites W2546819700 @default.
• W2122424316 cites W2617377817 @default.
• W2122424316 cites W2991792334 @default.
• W2122424316 cites W4205645630 @default.
• W2122424316 doi "https://doi.org/10.1016/j.ijcard.2015.03.323" @default.
• W2122424316 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25839640" @default.
• W2122424316 hasPublicationYear "2015" @default.
• W2122424316 type Work @default.
• W2122424316 sameAs 2122424316 @default.
• W2122424316 citedByCount "12" @default.
• W2122424316 countsByYear W21224243162016 @default.
• W2122424316 countsByYear W21224243162017 @default.
• W2122424316 countsByYear W21224243162019 @default.
• W2122424316 countsByYear W21224243162023 @default.
• W2122424316 crossrefType "journal-article" @default.
• W2122424316 hasAuthorship W2122424316A5002582638 @default.
• W2122424316 hasAuthorship W2122424316A5006163992 @default.
• W2122424316 hasAuthorship W2122424316A5012496275 @default.
• W2122424316 hasAuthorship W2122424316A5028923340 @default.
• W2122424316 hasAuthorship W2122424316A5055127245 @default.
• W2122424316 hasAuthorship W2122424316A5084192381 @default.
• W2122424316 hasAuthorship W2122424316A5086292433 @default.
• W2122424316 hasAuthorship W2122424316A5091070572 @default.
• W2122424316 hasConcept C126322002 @default.
• W2122424316 hasConcept C127413603 @default.
• W2122424316 hasConcept C156957248 @default.
• W2122424316 hasConcept C164705383 @default.
• W2122424316 hasConcept C2776131983 @default.
• W2122424316 hasConcept C2776301958 @default.
• W2122424316 hasConcept C2777185221 @default.
• W2122424316 hasConcept C2777289489 @default.
• W2122424316 hasConcept C2778661090 @default.
• W2122424316 hasConcept C2779161974 @default.
• W2122424316 hasConcept C2780645631 @default.
• W2122424316 hasConcept C42219234 @default.
• W2122424316 hasConcept C44249647 @default.
• W2122424316 hasConcept C71924100 @default.
• W2122424316 hasConcept C78519656 @default.
• W2122424316 hasConceptScore W2122424316C126322002 @default.
• W2122424316 hasConceptScore W2122424316C127413603 @default.
• W2122424316 hasConceptScore W2122424316C156957248 @default.
• W2122424316 hasConceptScore W2122424316C164705383 @default.
• W2122424316 hasConceptScore W2122424316C2776131983 @default.
• W2122424316 hasConceptScore W2122424316C2776301958 @default.
• W2122424316 hasConceptScore W2122424316C2777185221 @default.
• W2122424316 hasConceptScore W2122424316C2777289489 @default.
• W2122424316 hasConceptScore W2122424316C2778661090 @default.
• W2122424316 hasConceptScore W2122424316C2779161974 @default.
• W2122424316 hasConceptScore W2122424316C2780645631 @default.
• W2122424316 hasConceptScore W2122424316C42219234 @default.
• W2122424316 hasConceptScore W2122424316C44249647 @default.
• W2122424316 hasConceptScore W2122424316C71924100 @default.
• W2122424316 hasConceptScore W2122424316C78519656 @default.
• W2122424316 hasLocation W21224243161 @default.
• W2122424316 hasLocation W21224243162 @default.
• W2122424316 hasOpenAccess W2122424316 @default.
• W2122424316 hasPrimaryLocation W21224243161 @default.

• next